First author, Year of publication | Disorder type | Number of patients | Number of controls | Mean age of patients (yrs) | Mean age of controls (yrs) |
---|---|---|---|---|---|
FIRST EPISODE SCHIZOPHRENIA | Â | Â | Â | ||
  Berge, 2010 [32] | PNOS (FE) | 21 | 20 | 24.8 | 25.3 |
  Chua, 2007 [33] | SZ, SZF, BPSY (FE) | 26 | 38 | 32.0 | 33.0 |
  Douaud, 2007 [34] | SZ (FE) | 25 | 25 | 16.5 | 16.2 |
  Ebdrup, 2010 [35] | SZ (FE) | 38 | 43 | 26.2 | 26.9 |
  Jayakumar, 2005 [36] | SZ (FE) | 18 | 18 | 24.9 | 25.7 |
  Job, 2002 [37] | SZ (FE) | 34 | 36 | 21.4 | 21.2 |
  Kasparak, 2007 [38] | SZ (FE) | 22 | 18 | 23.7 | 24.1 |
  Kubicki, 2002 [39] | SZ (FE) | 16 | 18 | 26.0 | 24.0 |
  Lui, 2009 [40] | SZ (FE) | 68 | 68 | 24.2 | 24.7 |
  Meda, 2008 [41] | WPIC | 22 | 21 | 25.1 | 26.2 |
  Molina, 2010 [42] | SZ (FE) | 30 | 41 | 25.8 | 29.4 |
  Price, 2010 [43] | SCZ, SZA (FE) | 48 | 47 | 26.2 | 24.8 |
  Salgado-Pineda, 2003 [44] | SZ (FE) | 13 | 13 | 23.8 | 23.4 |
  Schaufelberger, 2007 [45] | SZ, SZF (FE) | 62 | 94 | 27.6 | 30.2 |
  Venkatasubramanian, 2010 [46] | SZ (FE) | 30 | 27 | 30.1 | 27.4 |
  Whitford, 2005 [47] | SZ (FES) | 41 | 47 | 19.8 | 19.3 |
  Witthaus, 2009 [48] | SZ (FES) | 23 | 29 | 26.4 | 25.7 |
  Yoshihara, 2008 [49] | SZ (FES) | 18 | 18 | 15.8 | 15.8 |
Total (mean) | Â | 555 (30.8) | 621 (34.5) | (24.4) | (24.5) |
FRONTO-TEMPORAL LOBAR DEGENERATION | Â | Â | Â | Â | |
  Adlam, 2006 [50] | FTLD: SD, fPPA | 6 | 12 | 62.8 | 65.0 |
  Boccardi, 2005 [51] | FTLD | 9 | 26 | 62.0 | 69.0 |
  Boxer, 2003 [52] | FTLD: SD | 11 | 15 | 66.2 | 69.6 |
  Chang, 2005 [53] | FTLD: FTLD&ALS vs. ALS | 10 | 10 | 64.5 | 49.9 |
  Desgranges, 2007 [54] | FTLD: SD | 10 | 17 | 65.7 | 65.8 |
  Gee, 2003 [55] | FTLD | 29 | 12 | 65.1 | 68.5 |
  Gorno-Tempini, 2004 [56] | FTLD: SD | 10 | 10 | 63.0 | 69.1 |
  Grossman, 2004 [57] | FTLD | 29 | 12 | 65.1 | 68.5 |
  Kanda, 2008 [58] | FTLD: bvFTD | 13 | 20 | 64.9 | 65.2 |
  Kim, 2007 [59] | FTLD | 14 | 61 | 63.3 | 68.0 |
  Libon 2009 [60] | FTLD: bvFTD | 51 | 43 | 61.3 | n/av: age-matched |
  Massimo 2009 [61] | FTLD: disinhibition-predominant | 4 | 10 | 63.6 | 64.1 |
  Mummery 2000 [62] | FTLD: SD | 6 | 14 | 60.5 | 62.0 |
  Nestor 2003 [63] | FTLD: PNFA | 7 | 10 | 71.5 | 65.9 |
  Pardini 2009 [64] | FTLD: bvFTD | 22 | 12 | 60.3 | n/av: age-matched |
  Pereira 2009 [65] | FTLD: ubiquitin positive | 9 | 25 | 64.0 | 63.8 |
  Rabinovici 2007 [66] | FTLD | 18 | 40 | 62.5 | 63.5 |
  Rosen 2002 [67] | FTLD: bvFTD | 20 | 20 | 61.8 | 62.3 |
  Seeley 2008 [68] | FTLD: bvFTD CDR2-3 | 15 | 45 | 62.3 | 68.3 |
  Williams 2005 [69] | FTLD | 18 | 17 | 60.8 | 61.7 |
Total (mean) | Â | 311 (15.6) | 431 (21.6) | (63.6) | (65.0) |